Articles

Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target

Hematopathology Unit, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Italy
Department of Systems Biology, Columbia University College of Physicians and Surgeons, New York, NY, USA;Department of Biomedical Informatics, Columbia University College of Physicians and Surgeons, New York, NY, USA
Division of Haematopathology, IEO European Institute of Oncology IRCCS, Milan, Italy
Laboratory of Hematology-Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy
Department of Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada
Hematopathology Unit, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Italy
Division of Haematopathology, IEO European Institute of Oncology IRCCS, Milan, Italy
Hematopathology Unit, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Italy
Dermatology Unit, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy;Division of Dermatology, Department of Surgery and Translational Medicine, University of Florence, Italy
Division of Haematopathology, IEO European Institute of Oncology IRCCS, Milan, Italy
Hematopathology Unit, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Italy
Hematopathology Unit, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Italy
Hematopathology Unit, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Italy
Division of Dermatology, Department of Surgery and Translational Medicine, University of Florence, Italy
Pathological Anatomy Histology & Cytogenetics, Niguarda Cancer Center, Niguarda-Ca' Granda Hospital, Milan, Italy
Institute of Hematology and Center for Hemato-Oncology Research (CREO), University and Hospital of Perugia, Italy
Universitätsklinik für Dermatologie und Venerologie, LKHUniversitatsklinikum Graz, Austria
Laboratory of Hematology-Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy
Department of Experimental Oncology, European Institute of Oncology, Milan, Italy
Department of Molecular Medicine and Medical Biotechnologies, University of Naples ‘Federico II’, Italy
"Giorgio Prodi" Cancer Research Center, University of Bologna, Italy
"Giorgio Prodi" Cancer Research Center, University of Bologna, Italy
Department of Systems Biology, Columbia University College of Physicians and Surgeons, New York, NY, USA
Unit of Anatomic Pathology, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS San Matteo Policlinic, Pavia, Italy
Department of Dermatology, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinic and Milan University, Milan, Italy
Pathology Section, Department of Molecular and Translational Medicine, University of Brescia, Italy
Department of Experimental Oncology, European Institute of Oncology, Milan, Italy;Department of Oncology and Hemato-Oncology, University of Milan, Italy
Laboratory of Hematology-Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy
Tumor Immunology Unit, Department of Health Science, Human Pathology Section, University of Palermo School of Medicine, Italy
Department of Systems Biology, Columbia University College of Physicians and Surgeons, New York, NY, USA;Department of Biomedical Informatics, Columbia University College of Physicians and Surgeons, New York, NY, USA
Division of Haematopathology, IEO European Institute of Oncology IRCCS, Milan, Italy
Vol. 104 No. 4 (2019): April, 2019 https://doi.org/10.3324/haematol.2018.202093